World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
49
Citations
16099
World Ranking
2597
National Ranking
1273

Christopher J. Ricketts publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Christopher J. Ricketts sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 115 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Christopher J. Ricketts D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher J. Ricketts sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 49 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Christopher J. Ricketts is a researcher affiliated with the National Institutes of Health in the United States. Their work primarily spans the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine.

Their research delves into multiple subfields including Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology, and Physiology. The topics covered in their publications reflect a focus on Renal cell carcinoma treatment, Renal and related cancers, Cancer Genomics and Diagnostics, Cancer, Hypoxia, and Metabolism, Epigenetics and DNA Methylation, Ferroptosis and cancer prognosis, and Tuberous Sclerosis Complex Research.

Christopher J. Ricketts has contributed extensively to academic journals, with notable frequent publication venues such as Urology, Cancer Research, The Journal of Urology, Cell, and Genes Chromosomes and Cancer.

Frequent collaborators include Cathy D. Vocke, W. Marston Linehan, Mark W. Ball, Maria J. Merino, and Martin Lang.

Key recent papers authored or co-authored by Christopher J. Ricketts include:

  • Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness, 2022, Cancer Cell
  • Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma, 2020, Cell
  • Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer, 2021, Science Signaling
  • Pan-cancer proteogenomics connects oncogenic drivers to functional states, 2023, Cell
  • Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention, 2020, Journal of Clinical Oncology

Best Publications

  • Comprehensivemolecular characterization of clear cell renal cell carcinoma

    Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

  • Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

    W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton

  • The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

    Caleb F. Davis;Christopher J. Ricketts;Min Wang;Lixing Yang

  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

    Christopher J Ricketts;Aguirre A De Cubas;Huihui Fan;Christof C Smith

  • Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

    David J. Clark;Saravana M. Dhanasekaran;Francesca Petralia;Jianbo Pan

  • The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications

    W Marston Linehan;Christopher J Ricketts

  • Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD

    Christopher J. Ricketts;Julia R. Forman;Eleanor Rattenberry;Nicola Bradshaw

  • Germline SDHB Mutations and Familial Renal Cell Carcinoma

    Christopher Ricketts;Emma R. Woodward;Pip Killick;Mark R. Morris

  • Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers

    Eric C. Kauffman;Christopher J. Ricketts;Soroush Rais-Bahrami;Youfeng Yang

  • Succinate Dehydrogenase Kidney Cancer: An Aggressive Example of the Warburg Effect in Cancer

    Christopher J. Ricketts;Brian Shuch;Cathy D. Vocke;Adam R. Metwalli

  • Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility

    Dewi Astuti;Mark R Morris;Mark R Morris;Wendy N Cooper;Raymond H J Staals

  • Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas

    Li Yao;Francesca Schiavi;Alberto Cascon;Yuejuan Qin

  • Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.

    Mark Morris;Christopher Ricketts;Dean Gentle;Fiona McRonald

  • The Metabolic Basis of Kidney Cancer.

    W. Marston Linehan;Laura S. Schmidt;Daniel R. Crooks;Darmood Wei

  • Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.

    Mark R. Morris;Christopher Ricketts;Dean Gentle;Mahera Abdulrahman

  • Defining Early-Onset Kidney Cancer: Implications for Germline and Somatic Mutation Testing and Clinical Management

    Brian Shuch;Srinivas Vourganti;Christopher J. Ricketts;Lindsay Middleton

  • Genome-wide DNA methylation profiling of CpG islands in breast cancer identifies novel genes associated with tumorigenicity

    Victoria K. Hill;Christopher Ricketts;Ivan Bieche;Sophie Vacher

  • A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma.

    Megan N. Farley;Laura S. Schmidt;Laura S. Schmidt;Jessica L. Mester;Samuel Peña-Llopis

  • Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075))

    Christopher J. Ricketts;Aguirre A. De Cubas;Huihui Fan;Christof C. Smith

  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (vol 23, pg 313, 2018)

    Christopher J Ricketts;Aguirre A De Cubas;Huihui Fan;Christof C Smith

Frequent Co-Authors

W. Marston Linehan
W. Marston Linehan National Institutes of Health
Laura S. Schmidt
Laura S. Schmidt National Institutes of Health
Eamonn R. Maher
Eamonn R. Maher University of Cambridge
Maria J. Merino
Maria J. Merino National Institutes of Health
Farida Latif
Farida Latif University of Birmingham
Paul S. Meltzer
Paul S. Meltzer National Institutes of Health
James J. Hsieh
James J. Hsieh Washington University in St. Louis
Toni K. Choueiri
Toni K. Choueiri Harvard University
Paul T. Spellman
Paul T. Spellman Oregon Health & Science University
Richard A. Gibbs
Richard A. Gibbs Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in expanding your expertise beyond molecular biology, there are many flexible online education options in the USA. For those considering a fast-track into healthcare, comparing programs like capella vs chamberlain rn to bsn can help you identify the best pathway for earning an RN to BSN degree. Graduates from a science background may also advance into specialized nursing by exploring accredited and online bsn to msn programs, which offer flexible learning for working professionals.

When researching online degrees, it’s important to look for well-regarded, reputable institutions. Many students choose not for profit online colleges to ensure quality education and recognized accreditation. In addition, those with military backgrounds or obligations can benefit from choosing an online college for military, which specializes in supporting active-duty and veteran students. These diverse online pathways open doors to rewarding careers in science, healthcare, and beyond.

Best Scientists Citing Christopher J. Ricketts

Trending Scientists

Recently Published Articles